Estimaciones de analistas de Wall Street para Protagenic Therapeutics, Inc. (PTIX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 1 |
| Calificación media (1-5) | 1.00 |
Ratios de valoración
| Ratio P/E | 0.28 |
| Precio / Valor contable | 0.88 |
| EV / EBITDA | -0.35 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $534 | $148 | $347 | $339 | $286 | 0 | $30 | $28218 | $50286 | $37715 |
| Beneficio Bruto | -$534 | -$148 | -$347 | -$339 | -$286 | 0 | -$30 | -$28218 | -$50286 | -$37715 |
| I+D | $417866 | $717452 | $881186 | $807947 | $699797 | $1.1M | $1.6M | $3.3M | $3.8M | $1.7M |
| Generales y Administrativos | $1.3M | $1.6M | $1.4M | $1.3M | $1.9M | $3.0M | $2.0M | $1.2M | $1.8M | $1.7M |
| Gastos Operativos | $1.8M | $2.4M | $2.3M | $2.1M | $2.6M | $4.1M | $3.6M | $4.5M | $5.7M | $5.8M |
| Beneficio Operativo | -$2.2M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.6M | -$4.5M | -$5.7M | -$5.8M |
| EBITDA | -$2.3M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.4M | -$4.5M | -$5.5M | -$8.0M |
| Gastos por Intereses | $7162 | $13890 | $2790 | $15886 | $246178 | $496912 | $137456 | $107682 | 0 | $296895 |
| Beneficio Antes de Impuestos | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| Impuestos | 0 | 0 | 0 | $15886 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| BPA | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| BPA Diluido | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| Acciones en Circulación (Diluidas) | $1.3M | $2.6M | $2.6M | $2.6M | $2.6M | $3.7M | $4.3M | $4.3M | $4.9M | $1.9M |
Precio
| Precio | $0.84 |
| Capitalización | $2M |
| Bolsa | OTC |
| País | US |
Empresas relacionadas: ARTL · CARM · GTBP · INDP · LIPO · PBM · REVB
Explorar sector: Healthcare · Biotechnology
Más secciones de PTIX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones